XML 26 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flow from operating activities:      
Net (loss) income $ (70,310) $ 113,565 $ (9,381)
Adjustments to reconcile net (loss) income to net cash flow provided by operating activities:      
Depreciation and amortization 402,045 419,079 324,129
Stock-based compensation 7,895 9,962 8,371
Amortization and write-off of deferred finance charges and fair market value of debt adjustments (5,315) (6,488) 4,930
Accretion of convertible debt discount 9,953 11,377 10,789
Equity in net loss (income) of joint ventures 3,135 (10,989) (6,819)
Impairment of joint venture investments 1,909 30,652 980
Net gain on sale and change in control of interests (7,772) (87,996) (19,906)
Operating cash distributions from joint ventures 8,382 10,749 15,116
Realized gain on sale of available-for-sale securities 0 (1,416) 0
Gain on disposition of real estate (167,571) (99,069) (11,741)
Impairment charges and loan loss reserves 279,021 38,552 72,597
Change in notes receivable accrued interest (8,048) (8,259) (5,756)
Change in restricted cash 1,111 7,060 3,610
Net change in accounts receivable (3,107) (2,357) (3,463)
Net change in accounts payable and accrued expenses 174 14,630 (18,651)
Net change in other operating assets and liabilities (16,915) (18,770) 9,169
Total adjustments 504,897 306,717 383,355
Net cash flow provided by operating activities 434,587 420,282 373,974
Cash flow from investing activities:      
Real estate acquired, net of liabilities and cash assumed (176,020) (330,929) (857,795)
Real estate developed and improvements to operating real estate (305,725) (260,897) (210,709)
Proceeds from disposition of real estate and joint venture interests 488,229 977,189 236,219
Equity contributions to joint ventures (6,142) (21,754) (21,043)
Issuance of joint venture advances, net (82,634) (258,248) (41,000)
Distributions from sale and refinancing of joint venture interests 10,678 15,565 2,429
Return of investments in joint ventures 7,445 10,128 7,450
Purchase of available-for-sale securities 0 0 (1,800)
Proceeds from sale of available-for-sale securities 0 3,216 0
Issuance of notes receivable 0 0 (26,555)
Repayment of notes receivable 9,521 1,436 18,326
Change in restricted cash 160 17,490 (3,381)
Net cash flow (used for) provided by investing activities (54,488) 153,196 (897,859)
Cash flow from financing activities:      
Proceeds from (repayments of) revolving credit facilities, net 182,371 2,110 (117,256)
Proceeds from issuance of senior notes, net of underwriting commissions and offering expenses 884,786 0 591,006
Repayments of senior notes (502,996) 0 0
Proceeds from mortgages and other secured debt 400,000 151,302 46,645
Repayment of term loans and mortgage debt (1,068,924) (497,238) (519,881)
Payment of debt issuance costs (4,605) (1,046) (3,999)
Redemption of preferred shares 0 (55,000) (150,000)
Proceeds from issuance of common shares, net of underwriting commissions and offering expenses 0 11,635 788,045
Proceeds from issuance of preferred shares, net of underwriting commissions and offering expenses 0 0 144,863
Issuance (repurchase) of common shares in conjunction with equity award plans and dividend reinvestment plan 2,325 (494) (4,416)
Contributions from non-controlling interests 0 93 374
Distributions to non-controlling interests and redeemable operating partnership units (6,452) (9,446) (1,565)
Dividends paid (265,277) (240,551) (194,497)
Net cash flow (used for) provided by financing activities (378,772) (638,635) 579,319
Cash and cash equivalents:      
Increase (decrease) in cash and cash equivalents 1,327 (65,157) 55,434
Effect of exchange rate changes on cash and cash equivalents 152 (570) 56
Cash and cash equivalents, beginning of year 20,937 86,664 31,174
Cash and cash equivalents, end of year $ 22,416 $ 20,937 $ 86,664